Skip to main content
. 2022 Jan 22;23(3):1242. doi: 10.3390/ijms23031242
3β-Adiol 5α-androstane-3β,17β-diol
8β-VE2 8-vinylestra-1:3,5 (10)-triene-3,17β-diol
AC adenylate cyclase
ACC adrenocortical cancer
ACTH adrenocorticotropic hormone
ADT androgen deprivation therapy
AF-1 transcriptional activation domain 1
AF-2 transcriptional activation domain 2
AI aromatase inhibitors
AKR1C1 aldo-keto reductase family 1 member C1
AKT protein kinase B
ANGII angiotensin II
AR + androgen receptor positive
AR androgen receptor
ARID1A AT-rich interactive domain-containing protein 1A
ATF4 activating transcription factor 4
ATF6 activating transcription factor 6
ATM ataxia telangiectasia
AVPC aggressive variant prostate cancer
BC breast cancer
BCL-2 B-cell lymphoma-2
BCSCs breast cancer stem cells
BH Bcl-2 homology
BH3 BCL-2 homology 3
BMP bone morphogenic protein
BPA bisphenol A
BPH benign prostatic hyperplasia
BRAF serine/threonine-protein kinase B-raf
BRCA1 BReast CAncer gene 1
BRCA2 BReast CAncer gene 2
C/EBPs CCAAT/enhancer binding proteins
Ca2+ calcium ion
cAMP cyclic adenosine monophosphate
CB1 cyclin B1
CCEC clear cell carcinoma
CCNE1 cyclin E1
CD1 cyclin D1
CDH1 E-cadherin gene
CDK4 cyclin dependent kinase 4
CDKN2A cyclin dependent kinase inhibitor 2a
c-FLIP FLICE/caspase-8-inhibitory protein
CHOP C/EBP homologous protein
CREB cAMP response element-binding protein
CReP constitutive repressor of eIF2a phosphorylation
CRPC castration resistant PC
CTNNB1 catenin beta 1
CYT C cytochrome c
DHT dihydrotestosterone
DPN 2:3-bis (4-hydroxyphenyl) propionitrile
DR4 or 5 death receptor 4 or 5
E2 estradiol
EAB estrogen and androgen blocking
EC endometrial cancer
ECM extracellular matrix
EGFR epidermal growth factor receptor
eIF2a initiation factor 2 alpha
EMT epithelial–mesenchymal transition
ER - ER negative
ER estrogen receptor
ER+ ER positive
ERE estrogen response element
ERK extracellular signal-regulated kinase
ERK1/2 extracellular signal-regulated kinase 1
ERs estrogen receptors
ERS reticulum endoplasmic stress
ERα estrogen receptor alpha
ERβ estrogen receptor beta
ESR1 estrogen receptor 1
ESR2 estrogen receptor 2
FADD Fas-associated protein with death domain
FAS fas cell surface death receptor
FASL FAS ligand
FLICE FADD (Fas-associated death domain)-like IL-1β–converting enzyme
C-FLIP cellular FLICE inhibitory protein
FOXL2 forkhead box protein L2
FOXO3a forkhead box O3a
FSH follicle-stimulating hormone
GADD34 growth-arrest- and DNA-damage-induced transcript 34
GPCR G-protein-coupled receptor
GPER G protein-coupled estrogen receptor 1
H3K4me3 histone H3 trimethylation of lysine 4
H3K9me3 histone H3 trimethylation of lysine 9
HER2 human epidermal growth factor receptor 2
Hi-Myc human c-Myc driven prostate cancer
HO-1 heme oxygenase 1
HRT hormone replacement therapy
IAP inhibitor apoptosis protein
IFITM1 IFN-induced transmembrane protein 1
IFNα interferon α
IGF1 insulin like growth factor 2
IGF1R insulin-like growth factor 1 receptor
IGF2 insulin like growth factor 2
IRE1-α inositol-requiring protein 1 alpha
JAK janus kinase
JNK c-Jun N-terminal kinase
KRAS kirsten rat sarcoma virus
LCT Leydig cell tumor
LH luteinizing hormone
LHRH luteinizing hormone releasing hormone
LTED long-term estrogen-deprived
LPS lipopolysaccharide
MAPK mitogen-activated protein kinase
MEK MAP kinase kinase
MYBL2 v-myb myeloblastosis viral oncogene homolog (avian)-like 2
MPs matrix metalloproteinases
mTOR mammalian target of rapamycin
MUC1 mucin 1
N-CoR nuclear receptor co-repressor 1
NF1 neurofibromatosis type 1
NF-κB nuclear factor kappa B
NO nitric oxide
OC ovarian cancer
OHT hydroxytamoxifen
PARP-1 poly (ADP-ribose) polymerase 1
PC prostate cancer
PDGFA platelet derived growth factor subunit A
PERK protein kinase RNA (PKR)-like endoplasmic reticular (ER)
PHTPP 4-[2-Phenyl-5:7-bis(trifluoromethyl)pyrazolo [1,5-a] pyrimidin-3-yl] phenol
PI3K phoshatidylinositol-3 kinase
PKA protein kinase A
PKC protein kinase C
PKG protein kinase G
PLC phospholipase C
POLE DNA polymerase epsilon, catalytic subunit
PPT 1:3,5-tris (4-hydroxyphenyl)-4-propyl-1H-pyrazole
PR progesterone receptor
PR-A progesterone receptor isoform A
PR-B progesterone receptor isoform B
PRKAR1A protein kinase cAMP-dependent regulatory type I alpha
PTEN phosphatase and tensin homolog
TFs transcription factors
PUMA p53 upregulated modulator of apoptosis
PXN paxillin
Rb retinoblastoma protein
RLX raloxifene
ROS reactive oxygen species
RPL22 ribosomal protein L22
SEC serous carcinoma
SERMs selective ER modulators
SFKs Src family kinases
SHBG sex hormone binding globulin
SMRT silencing mediator of retinoic acid and thyroid hormone receptor
STAT signal transducer and activator of transcription
STK11 serine/threonine kinase 11
SUV39H1 suppressor of variegation 3-9 homolog 1
SUV39H2 suppressor of variegation 3-9 homolog 2
TAF9B TATA-Box Binding Protein Associated Factor 9
TAM tamoxifen
TCs testicular cancers
TERF2 telomere specific protein 2
TFIID transcription factor IID
TGCTs testicular germ cell tumors
TGFβ1 transforming growth factor beta-1
TNBC triple negative breast cancers
TNF tumor necrosis factor
TNF-R1 tumor necrosis factor-receptor 1
TRADD tumor necrosis factor receptor type 1-associated death domain protein
TRAIL TNF-related apoptosis-inducing ligand
TRAIL TNF-related apoptosis-inducing ligand
TRAILR1 or -R2 TRAIL receptor
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling
UCS endometrial uterine carcinosarcoma
UPR unfolded protein response
VEGFA vascular endothelial growth factor A